AIDS. 2004 Oct 21;18(15):2009-17. doi: 10.1097/00002030-200410210-00005.
Antiretroviral drugs (ARV) as prophylaxis to prevent mother-to-child transmission of HIV results in decreased haematological parameters during and shortly after exposure, with recent data suggesting a more prolonged inhibition of haematopoiesis until at least 18 months.
Data on 156 HIV-infected and 1533 uninfected children in the European Collaborative Study followed from birth until at least 8 years of age.
Smoothers and splines were used to elucidate patterns over age; linear mixed effects allowed for repeated measurements. Covariates included the child's HIV-1 infection status, prematurity, gender, race, drug withdrawal symptoms at birth and ARV exposure; effects on neutrophil count were quantified in regression analyses using z-scores (SD from mean) of neutrophil counts obtained after modelling untransformed values using the LMS method. For HIV-infected children, progression to AIDS and ARV therapy were also included.
After approximately 4 months of age, neutrophil counts were consistently and substantially lower in HIV-infected children than in uninfected children; in both groups, black children had significantly lower counts than white children across the whole age range. In uninfected children, male gender and ARV exposure were associated with reduced neutrophil count until at least 8 years of age. In HIV-infected children, advanced disease and ARV treatment were significantly associated with neutrophil count.
A considerably longer effect of exposure to ARV was shown in uninfected children than previously thought and significant associations were shown between race and gender and neutrophil count, as previously observed for lymphocyte counts. The clinical relevance of these reduced levels of neutrophils requires further investigation.
抗逆转录病毒药物(ARV)作为预防母婴传播HIV的药物,在用药期间及用药后不久会导致血液学参数下降,近期数据表明其对造血功能的抑制作用会持续更长时间,至少持续18个月。
欧洲协作研究中156名感染HIV儿童和1533名未感染儿童的数据,从出生随访至至少8岁。
使用平滑器和样条来阐明随年龄变化的模式;线性混合效应模型用于处理重复测量数据。协变量包括儿童的HIV-1感染状态、早产、性别、种族、出生时的药物戒断症状和ARV暴露情况;在回归分析中,使用LMS方法对未转换值进行建模后获得的中性粒细胞计数的z分数(标准差与均值之差)来量化ARV暴露对中性粒细胞计数的影响。对于感染HIV的儿童,还纳入了艾滋病进展情况和ARV治疗情况。
大约4个月大后,感染HIV的儿童中性粒细胞计数持续且显著低于未感染儿童;在两个组中,黑人儿童在整个年龄范围内的中性粒细胞计数均显著低于白人儿童。在未感染儿童中,男性和ARV暴露与至少8岁前中性粒细胞计数降低有关。在感染HIV的儿童中,疾病进展和ARV治疗与中性粒细胞计数显著相关。
未感染儿童中ARV暴露的影响比之前认为的要长得多,并且种族、性别与中性粒细胞计数之间存在显著关联,正如之前观察到的淋巴细胞计数情况一样。中性粒细胞水平降低的临床相关性需要进一步研究。